393 related articles for article (PubMed ID: 23889668)
41. Impaired Left Ventricular Reserve in Childhood Cancer Survivors Treated With Anthracycline Therapy.
Kaneko S; Tham EB; Haykowsky MJ; Spavor M; Khoo NS; Mackie AS; Smallhorn JF; Thompson RB; Nelson MD
Pediatr Blood Cancer; 2016 Jun; 63(6):1086-90. PubMed ID: 26844944
[TBL] [Abstract][Full Text] [Related]
42. Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy.
Janbabai G; Nabati M; Faghihinia M; Azizi S; Borhani S; Yazdani J
Cardiovasc Toxicol; 2017 Apr; 17(2):130-139. PubMed ID: 27003392
[TBL] [Abstract][Full Text] [Related]
43. Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor.
Hu HM; Zhang XL; Zhang WL; Huang DS; Du ZD
Chin Med J (Engl); 2018 Jun; 131(12):1450-1456. PubMed ID: 29893362
[TBL] [Abstract][Full Text] [Related]
44. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
[TBL] [Abstract][Full Text] [Related]
45. Noninvasive early detection of anthracycline-induced cardiotoxicity in patients with hematologic malignancies using the phased tracking method.
Saito Y; Susukida I; Uzuka Y; Kanai H
Cancer Med; 2016 Sep; 5(9):2276-85. PubMed ID: 27484957
[TBL] [Abstract][Full Text] [Related]
46. Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters.
Díaz-Antón B; Madurga R; Zorita B; Wasniewski S; Moreno-Arciniegas A; López-Melgar B; Ramírez Merino N; Martín-Asenjo R; Barrio P; Amado Escañuela MG; Solís J; Parra Jiménez FJ; Ciruelos E; Castellano JM; Fernández-Friera L
ESC Heart Fail; 2022 Apr; 9(2):1127-1137. PubMed ID: 35106939
[TBL] [Abstract][Full Text] [Related]
47. Left ventricular endocardial dysfunction in patients with preserved ejection fraction after receiving anthracycline.
Miyoshi T; Tanaka H; Kaneko A; Tatsumi K; Matsumoto K; Minami H; Kawai H; Hirata K
Echocardiography; 2014 Aug; 31(7):848-57. PubMed ID: 24354985
[TBL] [Abstract][Full Text] [Related]
48. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Cohen V; Gosavi S; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
Am J Cardiol; 2011 May; 107(9):1375-80. PubMed ID: 21371685
[TBL] [Abstract][Full Text] [Related]
49. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study.
Galderisi M; Lomoriello VS; Santoro A; Esposito R; Olibet M; Raia R; Di Minno MN; Guerra G; Mele D; Lombardi G
J Am Soc Echocardiogr; 2010 Nov; 23(11):1190-8. PubMed ID: 20810245
[TBL] [Abstract][Full Text] [Related]
50. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
[TBL] [Abstract][Full Text] [Related]
51. Reliability of Left Ventricular Ejection Fraction from Three-Dimensional Echocardiography for Cardiotoxicity Onset Detection in Patients with Breast Cancer.
Lorenzini C; Lamberti C; Aquilina M; Rocca A; Cortesi P; Corsi C
J Am Soc Echocardiogr; 2017 Nov; 30(11):1103-1110. PubMed ID: 28822666
[TBL] [Abstract][Full Text] [Related]
52. Early detection of cardiotoxicity by 3D speckle tracking imaging of area strain in breast cancer patients receiving chemotherapy.
Chen J; Wang L; Wu FF; Sun G
Echocardiography; 2019 Sep; 36(9):1682-1688. PubMed ID: 31503352
[TBL] [Abstract][Full Text] [Related]
53. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity.
Hernandez-Suarez DF; López-Candales A
Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486
[TBL] [Abstract][Full Text] [Related]
54. Early Diagnosis of Cardiotoxicity in Patients Undergoing Chemotherapy for Acute Lymphoblastic Leukemia.
Militaru A; Zus S; Cimpean AM; Iurciuc S; Matusz P; Iurciuc M; Lighezan D; Militaru M
Anticancer Res; 2019 Jun; 39(6):3255-3264. PubMed ID: 31177176
[TBL] [Abstract][Full Text] [Related]
55. Screening for
Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
[TBL] [Abstract][Full Text] [Related]
56. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
[TBL] [Abstract][Full Text] [Related]
57. Subclinical Myocardial Impairment Occurred in Septal and Anterior LV Wall Segments After Anthracycline-Embedded Chemotherapy and did not Worsen During Adjuvant Trastuzumab Treatment in Breast Cancer Patients.
Lange SA; Jung J; Jaeck A; Hitschold T; Ebner B
Cardiovasc Toxicol; 2016 Apr; 16(2):193-206. PubMed ID: 26022230
[TBL] [Abstract][Full Text] [Related]
58. Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens.
de Vries Schultink AHM; Boekhout AH; Gietema JA; Burylo AM; Dorlo TPC; van Hasselt JGC; Schellens JHM; Huitema ADR
J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):431-442. PubMed ID: 29429038
[TBL] [Abstract][Full Text] [Related]
59. [Assessment of left ventricular twist mechanics by two-dimensional strain in severe aortic stenosis with preserved ejection fraction].
Meimoun P; Elmkies F; Benali T; Boulanger J; Zemir H; Clerc J; Luycx-Bore A
Ann Cardiol Angeiol (Paris); 2011 Nov; 60(5):259-66. PubMed ID: 21903195
[TBL] [Abstract][Full Text] [Related]
60. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.
Fallah-Rad N; Walker JR; Wassef A; Lytwyn M; Bohonis S; Fang T; Tian G; Kirkpatrick ID; Singal PK; Krahn M; Grenier D; Jassal DS
J Am Coll Cardiol; 2011 May; 57(22):2263-70. PubMed ID: 21616287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
